Although there is no cure for progressive supranuclear palsy, treatments are available to help ease symptoms of the disorder. The options include:
- Parkinson's disease medications, which increase levels of a brain chemical involved in smooth, controlled muscle movements (dopamine). The effectiveness of these medications is limited and usually temporary, lasting about two to three years.
- Botulinum toxin type A (Botox), which may be injected in small doses into the muscles around your eyes. Botox blocks the chemical signals that cause muscles to contract, which can improve eyelid spasms.
- Eyeglasses with bifocal or prism lenses, which may help ease problems with looking downward.
- Speech and swallowing evaluations, to help you learn safer swallowing techniques.
- Physical therapy and occupational therapy, to improve balance.
Researchers are working to develop medication to treat progressive supranuclear palsy, including therapies that may block the formation of tau.
April 10, 2014
- Factor SA. Progressive supranuclear palsy (PSP).http://www.uptodate.com/home. Accessed Dec. 3, 2013.
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Dec. 3, 2013.
- Ropper AH, et al. Adams & Victor's Principles of Neurology. 9th ed. New York, N.Y.: The McGraw-Hill Companies; 2009. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=54. Accessed Dec. 3, 2013.
- Boeve BF. Progressive supranuclear palsy. Parkinsonism and Related Disorders. 2012;18S1:S192.
- Josephs KA, et al. Modeling trajectories of regional volume loss in progressive supranuclear palsy. Movement Disorders. 2013;28:1117.
- Fujioka S, et al. Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy. Neurology. 2013;80:2076.
- Progressive supranuclear palsy fact sheet. National Institute of Neurological Disorders and Stroke. http://www.ninds.7.gov/disorders/psp/detail_psp.htm. Accessed Dec. 3, 2013.
- Liscic RM, et al. Differentiation of progressive supranuclear palsy: Clinical, imaging and laboratory tools. Acta Neurologica Scandinavica. 2013;127:362.
- Josephs KA, et al. A clinicopathological study of vascular progressive supranuclear palsy. Archives of Neurology. 2002;59:1597.
- Josephs KA, et al. Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Current Opinion in Neurology. 2008;21:688.
- Whitwell JL, et al. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. European Journal of Neurology. 2013;20:629.
- Whitwell JL, et al. Imaging measures predict progression in progressive supranuclear palsy. Movement Disorders. 2012;87:1801.
- Botha H, et al. The pimple sign of progressive supranuclear palsy. Parkinsonism and Related Disorders. In press. Accessed Dec. 3, 2013.
- Coon EA, et al. Primary lateral sclerosis as progressive supranuclear palsy: Diagnosis by diffusion tensor imaging. Movement Disorders. 2012;27:903.
- Josephs KA (expert opinion). Mayo Clinic, Rochester, Minn. Dec. 13, 2013.
- AskMayoExpert. Can rehabilitation help patients with Parkinson's disease and other movement disorders? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- A guide for people living with PSP, CBD, and other atypical Parkinsonian disorders. CurePSP. http://www.psp.org/education/. Accessed Dec. 4, 2013.